Diseases [C] » Wounds and Injuries [C26] » Fractures, Bone
Description
Breaks in bones. MeSH
Hierarchy View
Subtype Terms (28)
Ankle Fractures
20 drugs (15 approved, 5 experimental)
Femoral Fractures
10 drugs (9 approved, 1 experimental)
Fracture Dislocation
1 approved drug
Fractures, Closed
11 approved drugs
Fractures, Comminuted
1 approved drug
Fractures, Compression
6 approved drugs
Fractures, Open
12 drugs (11 approved, 1 experimental)
Fractures, Spontaneous
2 approved drugs
Fractures, Stress
11 drugs (7 approved, 4 experimental)
Fractures, Ununited
1 experimental drug
Humeral Fractures
4 approved drugs
Osteoporotic Fractures
9 drugs (7 approved, 2 experimental)
Radius Fractures
8 drugs (6 approved, 2 experimental)
Rib Fractures
20 drugs (18 approved, 2 experimental)
Shoulder Fractures
7 drugs (6 approved, 1 experimental)
Spinal Fractures
5 drugs (4 approved, 1 experimental)
Tibial Fractures
14 drugs (7 approved, 7 experimental)
Ulna Fractures
2 approved drugs
Phase 4 Indicated Drugs (59)
Phase 3 Indicated Drugs (17)
Phase 1 Indicated Drugs (3)
Other Experimental Indicated Drugs (22)
Organization Involved with Phase 4 Indications (105)
Canadian Institutes of Health Research (CIHR)
Fundacio Salut i Envelliment UAB
Good Samaritan Regional Medical Center, Oregon
Mercy Health Partners, Cincinnati
National Institute on Aging (NIA)
National Institutes of Health (NIH)
National University of Ireland
Ohio Orthopedic Center of Excellence
Oregon Health and Science University
Orthopaedic Trauma Association
Pontificia Universidad Catolica de Chile
Schweizerische Unfallversicherung SUVA, Switzerland
Triple O Research Institute PA
University of Alabama, Birmingham
University of California, Davis
University of California, Los Angeles
Organization Involved with Phase 3 Indications (55)
Assistance Publique - Hôpitaux de Paris
Centre de Recherche Rhumatologique et Thermal
Gerencia de Atención Primaria, Albacete
Hôpitaux Pédiatriques de Nice CHU-LENVAL
Hormozgan University of Medical Sciences
Instituto Mexicano del Seguro Social
Organization Involved with Phase 2 Indications (41)
Guangzhou Panyu Central Hospital
Hoosier Cancer Research Network
Huazhong University of Science and Technology
Illinosis Bone and Joint Institute
Organization Involved with Phase 1 Indications (7)
Organization Involved with Other Experimental Indications (52)
Bogomolets National Medical University
B P Koirala Institute of Health and Sciences
B.P. Koirala Institute of Health Sciences
Kassab Institute of Orthopedics
KK Women's and Children's Hospital
Lithuanian University of Health Sciences
Lomza State University of Applied Sciences
Muhimbili Orthopaedic Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National University of Malaysia
Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
